Home / 6-MP Tablet
6-MP Tablet

6-MP Tablet

(0 customer reviews)

$0.26 / unit

Available Options

Pack SizePricePrice / UnitQuantityAction
180 Tablets$35.00$0.19/unit
150 Tablets$30.00$0.20/unit
120 Tablets$24.00$0.20/unit
90 Tablets$19.00$0.21/unit
60 Tablets$14.00$0.23/unit
30 Tablets$8.00$0.27/unit
Looking for bulk / B2B pricing?

Product Description

What is this medicine?

6-MP TABLET contains Mercaptopurine 50 mg, also known as 6-mercaptopurine (6-MP). It is an antimetabolite / purine analogue anticancer medicine used mainly in the treatment of certain blood cancers.

Current Indian product information identifies 6-MP 50 mg Tablet as containing Mercaptopurine 50 mg and being marketed by Zydus Lifesciences Ltd..

Mercaptopurine interferes with the formation of DNA and RNA in rapidly dividing cells. This slows or stops the multiplication of abnormal blood cells.

This medicine is commonly used for:

  • acute lymphoblastic leukemia (ALL)

  • maintenance treatment of ALL

  • certain other leukemias when prescribed by an oncology specialist

  • combination chemotherapy regimens involving mercaptopurine

Mercaptopurine is particularly well established as part of maintenance therapy for acute lymphoblastic leukemia.

6-MP is a potent prescription anticancer medicine and should only be used under the supervision of an oncologist or other appropriately qualified specialist.


What should I tell my health care provider before I take this medicine?

They need to know if you have any of these conditions:

  • allergy to mercaptopurine

  • allergy to any ingredient in the tablet

  • liver disease

  • kidney disease

  • bone marrow problems

  • low white blood cell count

  • low platelet count

  • anemia

  • current or recurrent infection

  • previous serious infection

  • pancreatitis

  • previous severe reaction to mercaptopurine

  • previous treatment with chemotherapy

  • previous radiation therapy

  • TPMT deficiency

  • NUDT15 deficiency

  • pregnant or trying to get pregnant

  • breast-feeding

Tell your healthcare provider if you have previously taken azathioprine, because azathioprine is metabolized to mercaptopurine.

Before and during treatment, your healthcare provider may perform blood tests to check:

  • complete blood count

  • white blood cell count

  • platelet count

  • liver function

  • kidney function

Some patients have genetic differences in TPMT or NUDT15 enzymes that can substantially increase the risk of severe mercaptopurine toxicity. Your healthcare provider may consider testing or dose adjustment when appropriate.

Tell your healthcare provider about all prescription medicines, non-prescription medicines, vitamins, herbal products and dietary supplements you use.


How should I use this medicine?

Take 6-MP TABLET by mouth exactly as directed by your oncologist or healthcare professional.

The dose of mercaptopurine is individualized. It may depend on:

  • body weight or body surface area

  • type of leukemia

  • treatment protocol

  • blood-cell counts

  • liver function

  • kidney function

  • TPMT or NUDT15 activity

  • other chemotherapy medicines

  • response to treatment

  • treatment-related toxicity

Take your doses at regular intervals.

Current Indian information for 6-MP 50 mg states that the medicine may be taken with or without food, while the exact dose and frequency should be determined by the treating doctor.

Because food can affect mercaptopurine exposure, follow your oncology team's instructions consistently regarding meals.

Do not:

  • change your dose yourself

  • take more tablets than prescribed

  • stop treatment without consulting your oncologist

  • change the timing of treatment without medical advice

Overdosage: If you think you have taken too much mercaptopurine, contact your oncologist or emergency medical service immediately. Overdose can cause serious bone-marrow suppression, gastrointestinal symptoms and liver toxicity.

NOTE: This medicine is only for you. Do not share this medicine with others.


What if I miss a dose?

If you miss a dose of 6-MP, follow the instructions provided by your oncology team.

If you are unsure what to do, contact your doctor, oncology nurse or pharmacist.

Do not:

  • take two doses together

  • double the next dose

  • take extra tablets to compensate for a missed dose

Maintaining the prescribed treatment schedule is particularly important during leukemia maintenance therapy.

Repeatedly missing mercaptopurine doses can reduce treatment effectiveness; adherence to 6-MP during ALL maintenance therapy has been associated with relapse risk.


What may interact with this medicine?

Tell your healthcare provider if you take:

  • allopurinol

  • febuxostat

  • azathioprine

  • warfarin

  • mesalamine

  • sulfasalazine

  • olsalazine

  • other chemotherapy medicines

  • medicines that suppress bone marrow

  • medicines that affect liver function

  • certain immunosuppressive medicines

Important allopurinol interaction

Allopurinol can substantially increase mercaptopurine exposure and toxicity.

If both medicines are required, the mercaptopurine dose generally needs significant adjustment by a specialist.

Do not start allopurinol or another uric-acid-lowering medicine without informing the doctor managing your mercaptopurine treatment.

Vaccines

Tell your healthcare provider before receiving any vaccination.

Because mercaptopurine can suppress the immune system, live vaccines may need to be avoided during treatment.

This list may not describe all possible interactions.

Give your healthcare provider a list of all medicines, herbs, non-prescription drugs, vitamins and dietary supplements you use.


What should I watch for while using this medicine?

Visit your oncologist or healthcare professional for regular checks on your progress.

Regular laboratory monitoring is very important during mercaptopurine treatment.

Bone marrow suppression

Mercaptopurine can reduce the production of blood cells.

Contact your healthcare provider if you develop:

  • fever

  • chills

  • persistent sore throat

  • unusual tiredness

  • unusual weakness

  • unexplained bruising

  • unusual bleeding

  • frequent infections

Infection

Mercaptopurine can lower your body's ability to fight infections.

Avoid unnecessary close contact with people who have contagious illnesses and report signs of infection promptly.

Liver problems

Your healthcare provider may regularly monitor your liver function.

Contact your doctor if you develop:

  • yellowing of the skin or eyes

  • dark urine

  • severe or persistent nausea

  • unusual tiredness

  • upper abdominal pain

  • loss of appetite

Pancreatitis

Seek medical attention if you develop severe or persistent abdominal pain, particularly if accompanied by nausea or vomiting.

Sun exposure

Long-term immunosuppressive treatment may increase susceptibility to certain skin cancers.

Protect your skin from excessive sunlight and UV exposure. Use protective clothing and appropriate sunscreen when outdoors.


What side effects may I notice from this medicine?

Side effects that you should report to your doctor or health care professional as soon as possible:

  • fever or chills

  • persistent sore throat

  • signs of serious infection

  • unusual bleeding or bruising

  • severe weakness or tiredness

  • pale skin

  • severe abdominal pain

  • persistent nausea or vomiting

  • yellowing of the skin or eyes

  • dark urine

  • severe diarrhea

  • mouth ulcers

  • severe skin reaction

  • severe allergic reaction

  • swelling of the face, lips, tongue or throat

  • difficulty breathing or swallowing

Side effects that usually do not require immediate medical attention but should be reported if they continue or are bothersome:

  • nausea

  • vomiting

  • loss of appetite

  • diarrhea

  • stomach discomfort

  • mouth sores

  • tiredness

  • skin rash

Blood tests may also show:

  • low white blood cell count (leukopenia)

  • low neutrophil count

  • low platelet count

  • anemia

  • changes in liver enzymes

Because bone-marrow suppression can become serious, regular blood testing is an essential part of mercaptopurine treatment.

This list may not describe all possible side effects.


Where should I keep my medicine?

Keep 6-MP TABLETS out of the reach of children.

Current Indian product information identifies:

  • Brand Name: 6-MP 50 mg Tablet

  • Generic Name: Mercaptopurine / 6-Mercaptopurine

  • Strength: 50 mg

  • Dosage Form: Tablet

  • Therapeutic Class: Antineoplastic / Antimetabolite / Purine Analogue

  • Marketer: Zydus Lifesciences Ltd.

  • Pack Size: 10 tablets in the current retail listing

  • Route: Oral

  • Primary Use: Treatment/maintenance therapy of certain leukemias, particularly Acute Lymphoblastic Leukemia (ALL)

  • Country: India

  • Regulatory Status: Prescription anticancer medicine

  • Storage: Store below 25°C according to current Indian product information.

Keep the tablets:

  • in their original blister or container

  • protected from excessive heat

  • protected from moisture

  • away from direct sunlight

Follow the exact storage and handling instructions printed on the original 6-MP packaging.

Because mercaptopurine is a cytotoxic/anticancer medicine, handle it carefully and follow any specific handling instructions provided by your pharmacist or oncology team.

Do not use tablets that are damaged or have changed significantly in colour, appearance or physical condition.

Do not use 6-MP Tablets after the expiration date printed on the blister or outer packaging.